TrialIndian journal of ophthalmology2022

Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification.

Narayan Bardoloi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.